Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men

Publication date: November 2018

Source: American Journal of Preventive Medicine, Volume 55, Issue 5, Supplement 1

Author(s): Charles R. Rogers, Michael J. Rovito, Musse Hussein, Ogechi Jessica Obidike, Rebekah Pratt, Mark Alexander, Jerica M. Berge, Marc Dall'Era, Jeffrey W. Nix, Christopher Warlick

Introduction

Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted.

Methods

A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017.

Results

Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent.

Conclusions

Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research.

Supplement information

This article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2ynqNOE